Predicate |
Object |
assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_c92a515c01a8958f968fb1c4d7fb2d2d http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_ef2e9f5ce8630d9b282043b8d060caff http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_8b640a6e02238d721260eb4c2ff06bdd http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_ffff06f94237a26f3df264bd24c1de49 http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_e741e0d7724e8d1b97bff365ab321bb8 |
classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/Y10T428-2985 |
classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P43-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P27-06 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P27-02 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P9-10 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-0051 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-1647 |
classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-20 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-404 |
filingDate |
2005-04-27-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_7f986a913d84916ee9d639bdf73a7d20 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_80f33f4abfc8db7ee0509aee4f88448b http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_fa42c1f6ebfc9a90caf14c84ae0402db http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_3212c71171c12137836057835a436204 |
publicationDate |
2005-12-01-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber |
WO-2005112884-A1 |
titleOfInvention |
Intravitreal implants comprising microspheres which encapsulate a tyrosine kinase inhibitor and a biodegradable polymer |
abstract |
Biocompatible intraocular microspheres include a tyrosine kinase inhibitor and a biodegradable polymer that is effective to facilitate release of the tyrosine kinase inhibitor into the vitreous of an eye for an extended period of time. The therapeutic agents of the microspheres can be associated with a biodegradable polymer matrix. The microspheres can be placed into an eye to treat or reduce the occurrence of one or more ocular conditions. |
isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-9102830-B2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10434071-B2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11564890-B2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11202762-B2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11548861-B2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11160870-B2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11331276-B2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-8652504-B2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10485876-B2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10159747-B2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10888531-B2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10117950-B2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-9956302-B2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-9963549-B2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-9873764-B2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-9873765-B2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-9896544-B2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10098965-B2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10111964-B2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10441548-B2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-9517203-B2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-8349005-B2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-2009545516-A |
priorityDate |
2004-04-30-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type |
http://data.epo.org/linked-data/def/patent/Publication |